The National Institute on Drug Abuse is a component of the National Institutes of Health, . Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at http:// , which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s Drug Pubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or fax or email requests to 240-645-0227 or drugpubs@ . Online ordering is available at http:// . NIDA’s media guide can be found at http:///mediaguide , and its new easy-to-read website can be found at http:// .
In 2014, it began its commercial operations in Colombia and the acquisition of the minority stake in Chile. Offices were also opened in Venezuela, Paraguay and Ecuador for the submission of dossiers. Thus, the organization started to cover % of the Latin American market. With an established presence with own operations in 20 countries in South and Central America, in the Caribbean and Africa. in 2014, the company completed the negotiation, becoming a shareholder in the North American Melinta Therapeutics and made commercial agreements with leading companies in South Korea (Don-A) and Sri Lanka (Ceyoka).